Published in PLoS One on November 14, 2013
Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. Front Psychiatry (2015) 0.79
Genetics of structural connectivity and information processing in the brain. Brain Struct Funct (2016) 0.77
Novel mutation in the CHST6 gene causes macular corneal dystrophy in a black South African family. BMC Med Genet (2016) 0.75
Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models. PLoS One (2015) 0.75
Individual risk alleles of susceptibility to schizophrenia are associated with poor clinical and social outcomes. J Hum Genet (2015) 0.75
No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population. BMC Psychiatry (2016) 0.75
TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 81.13
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol (2010) 75.21
Differential expression analysis for sequence count data. Genome Biol (2010) 64.56
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet (2009) 12.96
Genome-wide association study identifies five new schizophrenia loci. Nat Genet (2011) 9.07
The classical complement cascade mediates CNS synapse elimination. Cell (2007) 9.06
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry (2007) 6.72
Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet (2012) 5.99
Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron (2012) 5.84
Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature (2011) 5.41
The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev (2005) 4.64
An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol (2012) 4.15
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science (2012) 3.17
Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature (2012) 3.08
Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol (2000) 3.03
From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat Neurosci (2012) 2.26
Impaired adult myelination in the prefrontal cortex of socially isolated mice. Nat Neurosci (2012) 2.20
MHC class I: an unexpected role in neuronal plasticity. Neuron (2009) 2.20
Prenatal infection as a risk factor for schizophrenia. Schizophr Bull (2006) 2.19
Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. Neuron (2009) 2.11
Therapeutic potential of complement modulation. Nat Rev Drug Discov (2009) 1.85
The acoustic startle response in rats--circuits mediating evocation, inhibition and potentiation. Behav Brain Res (1997) 1.83
Endophenotype: a conceptual analysis. Mol Psychiatry (2010) 1.82
CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol (2006) 1.81
Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev (2001) 1.67
The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS. Glia (2012) 1.59
Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res (2001) 1.54
The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol Psychiatry (2011) 1.36
Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord (2002) 1.31
Transcript map of the 8p23 putative tumor suppressor region. Genomics (2001) 1.15
Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits? Schizophr Bull (2010) 1.11
Synapse elimination during development and disease: immune molecules take centre stage. Biochem Soc Trans (2010) 1.10
Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder. World J Biol Psychiatry (2012) 1.04
Defining genetic determinants of the Metabolic Syndrome in the Framingham Heart Study using association and structural equation modeling methods. BMC Proc (2009) 1.03
High-throughput mouse knockouts provide a functional analysis of the genome. Cold Spring Harb Symp Quant Biol (2003) 0.99
Transcriptional silencing by single-stranded RNAs targeting a noncoding RNA that overlaps a gene promoter. ACS Chem Biol (2012) 0.97
Hypothalamic AMP-activated protein kinase as a mediator of whole body energy balance. Rev Endocr Metab Disord (2011) 0.95
Synaptic activity-induced global gene expression patterns in the dentate gyrus of adult behaving rats: induction of immunity-linked genes. Neuroscience (2007) 0.89
Comorbid anxiety in patients with psychosis. Psychiatr Danub (2009) 0.82
Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice. PLoS One (2012) 0.81
Lipogenic effects of psychotropic drugs: focus on the SREBP system. Front Biosci (Landmark Ed) (2011) 0.80
Body mass index (BMI) of drug-naïve psychotic adolescents based on a population of adolescent psychiatric inpatients. Eur Psychiatry (2008) 0.78
Brief report: enrichment of associations in genes with fibrosis, apoptosis, and innate immunity functions with cardiac manifestations of neonatal lupus. Arthritis Rheum (2012) 0.77
The genome sequence of Atlantic cod reveals a unique immune system. Nature (2011) 3.99
Familial diarrhea syndrome caused by an activating GUCY2C mutation. N Engl J Med (2012) 2.04
Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One (2010) 1.38
Identification of genes co-upregulated with Arc during BDNF-induced long-term potentiation in adult rat dentate gyrus in vivo. Eur J Neurosci (2006) 1.35
Dual regulation of translation initiation and peptide chain elongation during BDNF-induced LTP in vivo: evidence for compartment-specific translation control. J Neurochem (2006) 1.18
Gene expression profiles in rat brain disclose CNS signature genes and regional patterns of functional specialisation. BMC Genomics (2007) 1.08
Doublecortin and doublecortin-like are expressed in overlapping and non-overlapping neuronal cell population: implications for neurogenesis. J Comp Neurol (2012) 1.00
Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells. J Psychopharmacol (2010) 0.94
Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern. Sarcoma (2012) 0.93
Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells. BMC Pharmacol (2009) 0.93
Variants in doublecortin- and calmodulin kinase like 1, a gene up-regulated by BDNF, are associated with memory and general cognitive abilities. PLoS One (2009) 0.92
Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs. BMC Neurosci (2006) 0.91
Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology (Berl) (2008) 0.89
Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology (Berl) (2011) 0.89
Gene expression in the rat brain: high similarity but unique differences between frontomedial-, temporal- and occipital cortex. BMC Neurosci (2011) 0.84
Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One (2011) 0.83
Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal CDC25B expression as determinate of pharmacological effect. Br J Haematol (2013) 0.82
PRI-Modeler: extracting RNA structural elements from PDB files of protein-RNA complexes. FEBS Lett (2007) 0.80
Lipogenic effects of psychotropic drugs: focus on the SREBP system. Front Biosci (Landmark Ed) (2011) 0.80
Silencing of doublecortin-like (DCL) results in decreased mitochondrial activity and delayed neuroblastoma tumor growth. PLoS One (2013) 0.79
B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability. J Clin Invest (2015) 0.79
DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder. PLoS One (2012) 0.79
Blocking blue light during mania - markedly increased regularity of sleep and rapid improvement of symptoms: a case report. Bipolar Disord (2014) 0.77
EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis. J Clin Invest (2016) 0.76
LOC689986, a unique gene showing specific expression in restricted areas of the rodent neocortex. BMC Neurosci (2013) 0.75
[Mercy toward honesty]. Tidsskr Nor Laegeforen (2012) 0.75